SCHEMBL5331434

SCHEMBL5331434

O=S(=O)(c1ccccc1Cl)N1CCCN(c2ccccc2Cl)CC1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM4 P08173 7/20 0.64
HSD11B1 P28845 1/20 0.57
TSHR P16473 2/20 0.53
CYP3A4 P08684 1/20 0.53
CYP2C9 P11712 1/20 0.53
CYP2C19 P33261 1/20 0.53
LMNA P02545 3/20 0.52
MAPT P10636 3/20 0.52
KMT2A Q03164 2/20 0.51
MAPK1 P28482 2/20 0.50
CHRM2 P08172 1/20 0.49
CHRM5 P08912 1/20 0.49
CHRM1 P11229 1/20 0.49
CHRM3 P20309 1/20 0.49
GBA1 P04062 1/20 0.49
ALDH1A1 P00352 2/20 0.48
HTT P42858 2/20 0.48
GAA P10253 1/20 0.48
PKM P14618 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2961026 0.94 CHRM4 (0.62) CHRM4HSD11B1TSHRCYP3A4CYP2C9
SCHEMBL5360560 0.87 HSD11B1 (0.62) CHRM4HSD11B1TSHRKMT2AALDH1A1
SCHEMBL5350376 0.87 CHRM4 (0.63) CHRM4TSHRCYP3A4CYP2C9CYP2C19
SCHEMBL3223609 0.85 CHRM4 (0.57) CHRM4HSD11B1TSHRLMNAMAPT
SCHEMBL2963243 0.84 CHRM4 (0.56) CHRM4HSD11B1TSHRLMNAMAPT
SCHEMBL2961967 0.84 ALDH1A1 (0.61) CHRM4HSD11B1LMNAMAPTKMT2A
SCHEMBL3216764 0.84 ALDH1A1 (0.64) CHRM4HSD11B1TSHRLMNAMAPT
SCHEMBL10723724 0.83 CHRM4 (0.64) CHRM4TSHRCYP3A4CYP2C9CYP2C19
SCHEMBL4555453 0.82 TSHR (0.78) CHRM4TSHRCYP3A4CYP2C9CYP2C19
SCHEMBL31684034 0.82 TSHR (0.78) CHRM4TSHRCYP3A4CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007122411-A1 DIAZEPAN-1-YL-SULFONYL DERIVATIVES FOR THE TREATMENT OF METABOLIC SYNDROME ASTRAZENECA AB (SE) 2007-11-01 WO claimed
WO-2007122411-A1 DIAZEPAN-1-YL-SULFONYL DERIVATIVES FOR THE TREATMENT OF METABOLIC SYNDROME ASTRAZENECA AB (SE) 2007-11-01 WO disclosed